These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

174 related articles for article (PubMed ID: 27597161)

  • 1. Discovery of a new structural class of competitive hDHODH inhibitors with in vitro and in vivo anti-inflammatory, immunosuppressive effects.
    Shen W; Ren X; Zhu J; Xu Y; Lin J; Li Y; Zhao F; Zheng H; Li R; Cui X; Zhang X; Lu X; Zheng Z
    Eur J Pharmacol; 2016 Nov; 791():205-212. PubMed ID: 27597161
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Use of human Dihydroorotate Dehydrogenase (hDHODH) Inhibitors in Autoimmune Diseases and New Perspectives in Cancer Therapy.
    Lolli ML; Sainas S; Pippione AC; Giorgis M; Boschi D; Dosio F
    Recent Pat Anticancer Drug Discov; 2018; 13(1):86-105. PubMed ID: 29119937
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Design, synthesis and pharmacological evaluation of novel substituted quinoline-2-carboxamide derivatives as human dihydroorotate dehydrogenase (hDHODH) inhibitors and anticancer agents.
    Vyas VK; Variya B; Ghate MD
    Eur J Med Chem; 2014 Jul; 82():385-93. PubMed ID: 24929289
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Design, synthesis, biological evaluation and X-ray structural studies of potent human dihydroorotate dehydrogenase inhibitors based on hydroxylated azole scaffolds.
    Sainas S; Pippione AC; Giorgis M; Lupino E; Goyal P; Ramondetti C; Buccinnà B; Piccinini M; Braga RC; Andrade CH; Andersson M; Moritzer AC; Friemann R; Mensa S; Al-Kadaraghi S; Boschi D; Lolli ML
    Eur J Med Chem; 2017 Mar; 129():287-302. PubMed ID: 28235702
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Recent developments in the medicinal chemistry and therapeutic potential of dihydroorotate dehydrogenase (DHODH) inhibitors.
    Vyas VK; Ghate M
    Mini Rev Med Chem; 2011 Oct; 11(12):1039-55. PubMed ID: 21861807
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Lapachol, a compound targeting pyrimidine metabolism, ameliorates experimental autoimmune arthritis.
    Peres RS; Santos GB; Cecilio NT; Jabor VA; Niehues M; Torres BG; Buqui G; Silva CH; Costa TD; Lopes NP; Nonato MC; Ramalho FS; Louzada-Júnior P; Cunha TM; Cunha FQ; Emery FS; Alves-Filho JC
    Arthritis Res Ther; 2017 Mar; 19(1):47. PubMed ID: 28270195
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Rational Design of Benzylidenehydrazinyl-Substituted Thiazole Derivatives as Potent Inhibitors of Human Dihydroorotate Dehydrogenase with in Vivo Anti-arthritic Activity.
    Li S; Luan G; Ren X; Song W; Xu L; Xu M; Zhu J; Dong D; Diao Y; Liu X; Zhu L; Wang R; Zhao Z; Xu Y; Li H
    Sci Rep; 2015 Oct; 5():14836. PubMed ID: 26443076
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A Patent Review of Human Dihydroorotate Dehydrogenase (hDHODH) Inhibitors as Anticancer Agents and their Other Therapeutic Applications (1999-2022).
    Gehlot P; Vyas VK
    Recent Pat Anticancer Drug Discov; 2024; 19(3):280-297. PubMed ID: 37070439
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Discovery of a novel series of hDHODH inhibitors with anti-pulmonary fibrotic activities.
    Lu K; Zhao Y; Wu G; Hu H; Wang M; Gong G; Jiang Y
    Bioorg Chem; 2019 May; 86():44-51. PubMed ID: 30685643
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Discovery of diverse human dihydroorotate dehydrogenase inhibitors as immunosuppressive agents by structure-based virtual screening.
    Diao Y; Lu W; Jin H; Zhu J; Han L; Xu M; Gao R; Shen X; Zhao Z; Liu X; Xu Y; Huang J; Li H
    J Med Chem; 2012 Oct; 55(19):8341-9. PubMed ID: 22984987
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Design, synthesis, and biological evaluation of novel substituted benzamide derivatives bearing a 1,2,3-triazole moiety as potent human dihydroorotate dehydrogenase inhibitors.
    Lu K; Cai L; Zhang X; Wu G; Xu C; Zhao Y; Gong P
    Bioorg Chem; 2018 Feb; 76():528-537. PubMed ID: 29316525
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [F01WB-1315 A and B, two dihydroorotate dehydrogenase inhibitors from microbial metabolites].
    Qi Q; Lu X; Zheng Z; Li Y; Fan Y; Zhu J; Ren X; Cui X; Shi Y; Li S; Zhang H; Zhao B
    Wei Sheng Wu Xue Bao; 2009 Apr; 49(4):485-91. PubMed ID: 19621636
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Protective and anti-arthritic effects of deer antler aqua-acupuncture (DAA), inhibiting dihydroorotate dehydrogenase, on phosphate ions-mediated chondrocyte apoptosis and rat collagen-induced arthritis.
    Kim KS; Choi YH; Kim KH; Lee YC; Kim CH; Moon SH; Kang SG; Park YG
    Int Immunopharmacol; 2004 Jul; 4(7):963-73. PubMed ID: 15182735
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Development of a human dihydroorotate dehydrogenase (hDHODH) pharma-similarity index approach with scaffold-hopping strategy for the design of novel potential inhibitors.
    Shih KC; Lee CC; Tsai CN; Lin YS; Tang CY
    PLoS One; 2014; 9(2):e87960. PubMed ID: 24504131
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Recent advances of human dihydroorotate dehydrogenase inhibitors for cancer therapy: Current development and future perspectives.
    Zhang L; Zhang J; Wang J; Ren C; Tang P; Ouyang L; Wang Y
    Eur J Med Chem; 2022 Mar; 232():114176. PubMed ID: 35151222
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Human dihydroorotate dehydrogenase inhibitors, a novel approach for the treatment of autoimmune and inflammatory diseases.
    Leban J; Vitt D
    Arzneimittelforschung; 2011; 61(1):66-72. PubMed ID: 21355448
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Targeting Myeloid Differentiation Using Potent 2-Hydroxypyrazolo[1,5- a]pyridine Scaffold-Based Human Dihydroorotate Dehydrogenase Inhibitors.
    Sainas S; Pippione AC; Lupino E; Giorgis M; Circosta P; Gaidano V; Goyal P; Bonanni D; Rolando B; Cignetti A; Ducime A; Andersson M; Järvå M; Friemann R; Piccinini M; Ramondetti C; Buccinnà B; Al-Karadaghi S; Boschi D; Saglio G; Lolli ML
    J Med Chem; 2018 Jul; 61(14):6034-6055. PubMed ID: 29939742
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Synthesis of 2-,4,-6-, and/or 7-substituted quinoline derivatives as human dihydroorotate dehydrogenase (hDHODH) inhibitors and anticancer agents: 3D QSAR-assisted design.
    Vyas VK; Qureshi G; Oza D; Patel H; Parmar K; Patel P; Ghate MD
    Bioorg Med Chem Lett; 2019 Apr; 29(7):917-922. PubMed ID: 30738663
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Structural Optimization and Structure-Activity Relationship of 4-Thiazolidinone Derivatives as Novel Inhibitors of Human Dihydroorotate Dehydrogenase.
    Zeng F; Quan L; Yang G; Qi T; Zhang L; Li S; Li H; Zhu L; Xu X
    Molecules; 2019 Jul; 24(15):. PubMed ID: 31370178
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Antinociceptive and anti-inflammatory activities of Schefflera octophylla extracts.
    Chen Y; Tao S; Zeng F; Xie L; Shen Z
    J Ethnopharmacol; 2015 Aug; 171():42-50. PubMed ID: 25944007
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.